Bevacizumab and paclitaxel for breast cancer patients with CNS metastases

被引:1
|
作者
Labidi, S. [1 ]
Bachelot, T. [1 ]
Coquard, I. L. Ray [1 ]
Favier, B. [1 ]
Galy, G. [1 ]
Guastalla, J. [1 ]
机构
[1] Ctr Leon Berard, F-69373 Lyon, France
关键词
D O I
10.1200/jco.2008.26.15_suppl.12009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12009
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series
    Labidi, Sana Intidhar
    Bachelot, Thomas
    Ray-Coquard, Isabelle
    Mosbah, Karim
    Treilleux, Isabelle
    Fayette, Jerome
    Favier, Bertrand
    Galy, Guillaume
    Blay, Jean-Yves
    Guastalla, Jean-Paul
    CLINICAL BREAST CANCER, 2009, 9 (02) : 118 - 121
  • [2] CNS metastases in breast cancer
    Lin, NU
    Bellon, JR
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) : 3608 - 3617
  • [3] CNS metastases in breast cancer patients treated with trastuzumab
    Globokar, T
    Borstnar, S
    Cufer, T
    Pajk, B
    Cervek, J
    ANNALS OF ONCOLOGY, 2005, 16 : 278 - 279
  • [4] Oncology Breast Cancer: Bevacizumab/Capecitabine Bevacizumab/Paclitaxel
    Lichert, Frank
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (12) : 1209 - 1209
  • [5] A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients
    Coltelli, Luigi
    Allegrini, Giacomo
    Orlandi, Paola
    Finale, Chiara
    Fontana, Andrea
    Masini, Luna Chiara
    Scalese, Marco
    Arrighi, Giada
    Barletta, Maria Teresa
    De Maio, Ermelinda
    Banchi, Marta
    Fini, Elisabetta
    Guidi, Patrizia
    Frenzilli, Giada
    Donati, Sara
    Giovannelli, Simona
    Tanganelli, Lucia
    Salvadori, Barbara
    Livi, Lorenzo
    Meattini, Icro
    Pazzagli, Ilaria
    Di Lieto, Marco
    Pistelli, Mirco
    Casadei, Virginia
    Ferro, Antonella
    Cupini, Samanta
    Orlandi, Francesca
    Francesca, Damiana
    Lorenzini, Giulia
    Barellini, Leonardo
    Falcone, Alfredo
    Cosimi, Alessandro
    Bocci, Guido
    NPJ BREAST CANCER, 2022, 8 (01)
  • [6] A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients
    Luigi Coltelli
    Giacomo Allegrini
    Paola Orlandi
    Chiara Finale
    Andrea Fontana
    Luna Chiara Masini
    Marco Scalese
    Giada Arrighi
    Maria Teresa Barletta
    Ermelinda De Maio
    Marta Banchi
    Elisabetta Fini
    Patrizia Guidi
    Giada Frenzilli
    Sara Donati
    Simona Giovannelli
    Lucia Tanganelli
    Barbara Salvadori
    Lorenzo Livi
    Icro Meattini
    Ilaria Pazzagli
    Marco Di Lieto
    Mirco Pistelli
    Virginia Casadei
    Antonella Ferro
    Samanta Cupini
    Francesca Orlandi
    Damiana Francesca
    Giulia Lorenzini
    Leonardo Barellini
    Alfredo Falcone
    Alessandro Cosimi
    Guido Bocci
    npj Breast Cancer, 8
  • [7] SURVIVAL OF BREAST CANCER PATIENTS WITH SYNCHRONOUS OR METACHRONOUS CNS METASTASES
    Ho, V. K. Y.
    Gijtenbeek, J. M. M.
    Brandsma, D.
    Beerepoot, L. V.
    Sonke, G. S.
    van der Heiden-van der Loo, M.
    NEURO-ONCOLOGY, 2014, 16
  • [8] Development of CNS Metastases and Survival in Patients With Inflammatory Breast Cancer
    Uemura, Marc I.
    French, John T.
    Hess, Kenneth R.
    Liu, Diane
    Raghav, Kanwal
    Hortobagyi, Gabriel N.
    Arun, Banu K.
    Valero, Vicente
    Ueno, Naoto T.
    Alvarez, Ricardo H.
    Woodward, Wendy A.
    Debeb, Bisrat G.
    Moulder, Stacy L.
    Lim, Bora
    Tripathy, Debu
    Ibrahim, Nuhad K.
    CANCER, 2018, 124 (11) : 2299 - 2305
  • [9] Paclitaxel plus bevacizumab for metastatic breast cancer
    Haines, Ian E.
    Miklos, George L. Gabor
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1637 - 1637
  • [10] Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
    Miller, Kathy
    Wang, Molin
    Gralow, Julie
    Dickler, Maura
    Cobleigh, Melody
    Perez, Edith A.
    Shenkier, Tamara
    Cella, David
    Davidson, Nancy E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26): : 2666 - 2676